The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.
Allergy. 2019 Sep;74(9):1716-1726. doi: 10.1111/all.13850. Epub 2019 Jul 1.
Allergy. 2019.
PMID: 31049972
Free PMC article.
Clinical Trial.